Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Lippo Karawaci TbkPTLKF 70 5-Year Yield-on-Cost % is 0.00 as of Jul. 31, 2026. GuruFocus rates PTLKF with a GF Score™ of 70/100 and a GF Value™ of $0.01. The stock has 4 warning signs investors should review. Among 275 Healthcare Providers & Services companies, PT Lippo Karawaci Tbk ranks worse than 363636% on this metric.
PT Lippo Karawaci Tbk's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for PT Lippo Karawaci Tbk's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, PT Lippo Karawaci Tbk's highest Yield on Cost was 1.09. The lowest was 0.00. And the median was 0.45.
PTLKF's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.93 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
PT Lippo Karawaci Tbk 5-Year Yield-on-Cost % Related Terms
PTLKF vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, PT Lippo Karawaci Tbk's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Lippo Karawaci Tbk 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Lippo Karawaci Tbk's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where PT Lippo Karawaci Tbk's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
PT Lippo Karawaci Tbk (PTLKF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Lippo Karawaci Tbk and its competitors. According to the industry distribution chart, PT Lippo Karawaci Tbk ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is PT Lippo Karawaci Tbk's 5-Year Yield-on-Cost % too high?
PT Lippo Karawaci Tbk's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, PT Lippo Karawaci Tbk ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Lippo Karawaci Tbk has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does PT Lippo Karawaci Tbk's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Lippo Karawaci Tbk ranks #999999 out of 275 companies for 5-Year Yield-on-Cost %. This places PT Lippo Karawaci Tbk in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Lippo Karawaci Tbk and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Lippo Karawaci Tbk's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Lippo Karawaci Tbk stock overvalued right now?
PT Lippo Karawaci Tbk (PTLKF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. PT Lippo Karawaci Tbk's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For PT Lippo Karawaci Tbk (PTLKF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Lippo Karawaci Tbk (PTLKF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Lippo Karawaci Tbk stock appears to be overvalued.
The current stock price of $0.01 is trading 4% above its estimated GF Value™ of $0.01.
Key valuation signals for PTLKF:
5-Year Yield-on-Cost %: 0.00
GF Value™: $0.01 vs. price of $0.01 (4% above fair value)
No single metric tells the full story. See the PTLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Lippo Karawaci Tbk is engaged in property development activities including area development, residential property development and sales, commercial property, light industrial property, and integrated property projects. As part of its large scale integrated development portfolio, the Company develops projects within strategic locations comprising residential, office, mall, hotel, entertainment, education, and healthcare facilities. Its portfolio includes residential and urban development, hospitals, malls, and hotels and leisure assets. The Company has developed and manages urban property areas mainly in Java and Sulawesi, and operates across real estate, lifestyle, and healthcare segments, providing services across Indonesia.
70GF Score
Get the complete analysis for PTLKF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PTLKF has been successfully added to your 
